Stocks
Atreca, Inc.BCEL
NASDAQHealthcareBiotechnology$0.09-1.32%
A clinical-stage biotechnology company focused on discovering and developing antibody-based therapeutics derived from human immune responses. Its platform analyzes B‑cell immune repertoires to identify potential drug candidates, with programs historically targeting oncology and infectious diseases. ...
Market Cap: $3.6M52W Range: $0.05 – $1.20
This page tracks all publicly disclosed congressional trades in Atreca, Inc. (BCEL), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-06-16 | Christopher L. Jacobs | buy | $15K – $50K |